Product Overview
[Drug Name]
Generic Name: Ranitidine Hydrochloride Capsules
Trade Name: Xiren Ranitidine Hydrochloride Capsules, 30 Capsules/Bottle
Pinyin Full Code: XiRen YanSuanLeiNiTiDingJiaoNang 30Li/Ping
[Main Ingredients]
Each capsule contains 0.15g of ranitidine hydrochloride (calculated as ranitidine). Excipients: calcium carbonate, silicon dioxide, magnesium stearate.
[Indications/Main Functions]
Benign gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux esophagitis, Zollinger-Ellison syndrome.
[Specifications]
30 capsules/bottle (Xiren)
[Dosage and Administration]
Oral: For ulcer disease: 150 mg/time, twice daily, in the morning and at bedtime. For Zollinger-Ellison syndrome: 150 mg/time, three times daily, up to 900 mg/day if necessary. Children over 8 years old: 75-150 mg twice daily. Intramuscular injection: 50 mg/time, twice daily. Intravenous infusion: 100-300 mg/day, or 25 mg/hour, twice daily or every 6-8 hours.
[Adverse Reactions]
Nausea, rash, constipation, fatigue, headache, and dizziness may occur; bradycardia may occasionally occur after intravenous injection; mild liver damage is rare. Long-term use can continuously reduce gastric acidity, promoting bacterial growth in the stomach.
[Contraindications]
Not suitable for children under 8 years old.
Not suitable for pregnant and lactating women.
[Precautions]
Use with caution in patients with hepatic impairment and the elderly; the dose should be halved for patients with severe renal impairment. Use in pregnant women and infants only when absolutely necessary. Not suitable for children under 8 years old.
[Pediatric Use]
Not suitable for children under 8 years old.
[Pregnant and lactating women]
Not suitable for pregnant and lactating women.
[Storage]
Store in a dark, dry, and tightly sealed container.
[Validity Period]
36 months
[Approval Number]
National Medicine Approval No. H23023162
[Manufacturer]
Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd.
